EA201991797A1 - A HIGHLY ACTIVE AND SHORT PROMOTOR INTENDED FOR EXPRESSION OF HETEROLOGICAL GENES - Google Patents

A HIGHLY ACTIVE AND SHORT PROMOTOR INTENDED FOR EXPRESSION OF HETEROLOGICAL GENES

Info

Publication number
EA201991797A1
EA201991797A1 EA201991797A EA201991797A EA201991797A1 EA 201991797 A1 EA201991797 A1 EA 201991797A1 EA 201991797 A EA201991797 A EA 201991797A EA 201991797 A EA201991797 A EA 201991797A EA 201991797 A1 EA201991797 A1 EA 201991797A1
Authority
EA
Eurasian Patent Office
Prior art keywords
expression
intended
highly active
heterological
genes
Prior art date
Application number
EA201991797A
Other languages
Russian (ru)
Inventor
Керстин Вундерлих
Тако Жилль Эйл
Йорт Веллинга
Барбара Петронелла Сандерс
Ремко Ван Дер Влюгт
Original Assignee
Янссен Вэксинс Энд Превеншн Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Вэксинс Энд Превеншн Б.В. filed Critical Янссен Вэксинс Энд Превеншн Б.В.
Priority claimed from PCT/EP2018/053201 external-priority patent/WO2018146205A1/en
Publication of EA201991797A1 publication Critical patent/EA201991797A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
    • C12N2830/006—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

В настоящем изобретении представлен промотор AoHV-1 для применения с плазмидными векторами, вирусными векторами, вирусами и клеточными линиями, содержащими промотор AoHV-1, функционально связанный с трансгеном. В настоящем изобретении также представлены способы получения и применения рекомбинантных плазмидных векторов, вирусных векторов, вирусов и клеточных линий, содержащих промотор AoHV-1, функционально связанный с трансгеном.The present invention provides an AoHV-1 promoter for use with plasmid vectors, viral vectors, viruses, and cell lines containing the AoHV-1 promoter operably linked to a transgene. The present invention also provides methods for producing and using recombinant plasmid vectors, viral vectors, viruses, and cell lines containing the AoHV-1 promoter operably linked to a transgene.

EA201991797A 2017-03-28 2018-02-08 A HIGHLY ACTIVE AND SHORT PROMOTOR INTENDED FOR EXPRESSION OF HETEROLOGICAL GENES EA201991797A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17163245 2017-03-28
PCT/EP2018/053201 WO2018146205A1 (en) 2017-02-09 2018-02-08 Potent and short promoter for expression of heterologous genes

Publications (1)

Publication Number Publication Date
EA201991797A1 true EA201991797A1 (en) 2020-01-14

Family

ID=58448432

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991797A EA201991797A1 (en) 2017-03-28 2018-02-08 A HIGHLY ACTIVE AND SHORT PROMOTOR INTENDED FOR EXPRESSION OF HETEROLOGICAL GENES

Country Status (1)

Country Link
EA (1) EA201991797A1 (en)

Similar Documents

Publication Publication Date Title
MX2019009316A (en) Potent and short promoter for expression of heterologous genes.
CL2018000587A1 (en) Oncolytic adenovirus encoding a b7 protein (divisional sol. No. 2731-2017)
MX2022006652A (en) Modified capsid proteins for enhanced delivery of parvovirus vectors.
CY1123413T1 (en) LENTIC CARRIERS
CL2016000502A1 (en) Enhanced vectors of adeno-associated virus factor viii less than 5.0 kb in length, which produce a functionally active factor viii polypeptide for the treatment of hemophilia a.
CL2017002199A1 (en) Retroviral to Lentiviral Vectors
BR112017017867A2 (en) methods and compositions for treating genetic eye disease
EA202190827A1 (en) VIRAL VECTORS CODING RECOMBINANT FVIII VARIANTS WITH INCREASED EXPRESSION FOR GENE THERAPY OF HEMOPHILIA A
EA201890640A1 (en) RECOMBINANT VECTORS CONTAINING PEPTIDE 2A
ZA201907716B (en) Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia b
EA201890351A1 (en) RECOMBINANT ORF-VIRAL VECTOR
PE20191786A1 (en) MONOCLONAL ANTIBODY FOR PD-L1
EA201891138A1 (en) VIRAL VECTORS ENCODING FVIII RECOMBINANT OPTIONS WITH INCREASED EXPRESSION FOR HEMOPHILIA A GENE THERAPY
MX366836B (en) Avian cells for improved virus production.
EA201991797A1 (en) A HIGHLY ACTIVE AND SHORT PROMOTOR INTENDED FOR EXPRESSION OF HETEROLOGICAL GENES
IN2014DN10123A (en)
EA202192053A1 (en) CHIMERIC PROMOTORS FOR USE IN METABOLIC DESIGN
WO2018013705A8 (en) Use of glucocorticoid analogs to enhance recombinant adeno-associated virus yield
EA202091958A1 (en) RECOMBINANT VIRAL VECTOR SYSTEMS EXPRESSING EXOGENIC GENES OF FIT PARAMIXOVIRUS AND VACCINES PREPARED FROM THEM
ECSP23024245A (en) NUCLEIC ACID CONSTRUCTS, VIRAL VECTORS AND VIRAL PARTICLES
MY185846A (en) Oncolytic adenovirus encoding a b7 protein
EA201991805A1 (en) MULTIPLE TRANSGENIC RECOMBINANT Adenovirus
EA201890595A1 (en) ONCOLYTIC ADENOVIRUS, ENCODING B7 PROTEIN
MY178599A (en) Inducible pmt-gfpubx vector and its uses thereof